China Dasheng Biotechnology Company (CDBT)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2008 | 2006 |
|---|---|---|---|---|
| Operating Cash Flow | -233.55 Thousand | - | 4.09 Million | 6081.00 |
| Net Income | -966.71 Thousand | - | 4.63 Million | -16.86 Thousand |
| Depreciation & Amortization | - | - | 626.36 Thousand | 1620.00 |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | 43.91 Thousand | - | -1.78 Million | 21.32 Thousand |
| Other non-cash items | 689.25 Thousand | - | 616.34 Thousand | - |
| Investing Cash Flow | 6216.00 | - | -3.91 Million | - |
| Investments in PPE | - | - | -30.68 Thousand | - |
| Acquisitions | 6216.00 | - | - | - |
| Investment purchases | - | - | -5.1 Million | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | - | 1.21 Million | - |
| Financing Cash Flow | 334.33 Thousand | - | -927.01 Thousand | - |
| Debt repayment | -122.18 Thousand | - | - | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | - | - | - | - |
| Other Financing Activities | 456.52 Thousand | - | -927.01 Thousand | - |
| Accounts receivables | - | - | - | - |
| Accounts payables | - | - | - | - |
| Inventory | - | - | 271.55 Thousand | 1348.00 |
| Other working capital | 43.91 Thousand | - | -2.05 Million | 19.97 Thousand |
| Cash at beginning of period | - | - | 1.31 Million | 1056.00 |
| Cash at end of period | 7291.00 | - | 1.56 Million | 7137.00 |
| Capital Expenditure | - | - | -30.68 Thousand | - |
| Effect of forex changes on cash | -99.71 Thousand | - | 991.14 Thousand | - |
| Net cash flow / Change in cash | 7291.00 | - | 244.83 Thousand | 6081.00 |
| Free Cash Flow | -233.55 Thousand | - | 4.06 Million | 6081.00 |
| Breakdown | 2022 FY | 2021 FY | 2008 Q3 | 2008 Q2 | 2008 Q1 | 2007 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -966.71 Thousand | - | 1.3 Million | 1.73 Million | 1.32 Million | 2.04 Million |
| Depreciation & Amortization | - | - | 202.26 Thousand | 137.59 Thousand | 67.12 Thousand | 279.13 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 43.91 Thousand | - | 1.17 Million | 2.16 Million | -1.33 Million | -873.38 Thousand |
| Other non-cash items | 689.25 Thousand | - | 293.5 Thousand | 369.96 Thousand | 321.45 Thousand | 616.34 Thousand |
| Investing Cash Flow | 6216.00 | - | -449.37 Thousand | 1935.00 | - | -3.88 Million |
| Investments in PPE | - | - | - | - | - | -2278.00 |
| Acquisitions | 6216.00 | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -3.88 Million |
| Financing Cash Flow | 334.33 Thousand | - | -2438.00 | 1.19 Million | 321.08 Thousand | -667.67 Thousand |
| Debt repayment | -122.18 Thousand | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 456.52 Thousand | - | - | - | - | -667.67 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -12.01 Thousand | -27.81 Thousand | -43.79 Thousand | 74.6 Thousand |
| Other working capital | - | - | 1.19 Million | 2.19 Million | -1.29 Million | -947.99 Thousand |
| Cash at beginning of period | - | - | 7.82 Million | 2.38 Million | 1.56 Million | 3.34 Million |
| Cash at end of period | 7291.00 | - | 10.41 Million | 7.82 Million | 2.38 Million | 1.56 Million |
| Capital Expenditure | - | - | - | - | - | -2278.00 |
| Effect of forex changes on cash | -99.71 Thousand | - | 64.37 Thousand | -156.6 Thousand | 118.16 Thousand | 713.82 Thousand |
| Net cash flow / Change in cash | 7291.00 | - | 2.59 Million | 5.43 Million | 820.33 Thousand | -1.77 Million |
| Free Cash Flow | -233.55 Thousand | - | 2.97 Million | 4.4 Million | 381.08 Thousand | 2.06 Million |
EYUBY
GLTO
CNER
ALSAU
000036
TAKD